Literature DB >> 9247589

Mouse macrophage development in the absence of the common gamma chain: defining receptor complexes responsible for IL-4 and IL-13 signaling.

A Andersson1, S M Grunewald, A Duschl, A Fischer, J P DiSanto.   

Abstract

The common gamma chain (gamma c) forms a critical component of the receptors for interleukins (IL)-2, IL-4, IL-7, IL-9, and IL-15. We analyzed gamma c-deficient mice to define a role for gamma c signaling in the development and function of the macrophage lineage. No major differences in absolute cell numbers, cell surface phenotype, or in vitro function of gamma c- compared to gamma c+ macrophages were observed. We therefore conclude that signaling through the gamma c chain is not essential for the differentiation of mouse macrophages. Although B and T cells require gamma c for IL-4 responses, IL-4 up-regulated major histocompatibility class II molecules and inhibited nitric oxide production from gamma c- macrophages following stimulation with lipopolysaccharide and interferon-gamma. gamma c- macrophages could also respond to IL-13, consistent with the model of a type II IL-4 receptor alpha/IL-13R which can function in the absence of gamma c. Both IL-4 and IL-13 responses could be completely inhibited with the mouse IL-4 antagonist OY, suggesting that all of the observed IL-13 responses pass through the type II receptor, making it the primary signaling receptor complex for IL-13 in mouse macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247589     DOI: 10.1002/eji.1830270725

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.

Authors:  Faruk Sheikh; Harold Dickensheets; Joao Pedras-Vasconcelos; Thirumalai Ramalingam; Laura Helming; Siamon Gordon; Raymond P Donnelly
Journal:  J Innate Immun       Date:  2015-03-07       Impact factor: 7.349

4.  Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity.

Authors:  Ilkka S Junttila; Kiyoshi Mizukami; Harold Dickensheets; Martin Meier-Schellersheim; Hidehiro Yamane; Raymond P Donnelly; William E Paul
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

5.  Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

Authors:  Nicola M Heller; Xiulan Qi; Ilkka S Junttila; Kari Ann Shirey; Stefanie N Vogel; William E Paul; Achsah D Keegan
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

6.  Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?

Authors:  René Rückert; Katja Brandt; Martin Ernst; Kathleen Marienfeld; Elena Csernok; Claudia Metzler; Vadim Budagian; Elena Bulanova; Ralf Paus; Silvia Bulfone-Paus
Journal:  Immunology       Date:  2008-06-13       Impact factor: 7.397

7.  Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor.

Authors:  L S Park; U Martin; K Garka; B Gliniak; J P Di Santo; W Muller; D A Largaespada; N G Copeland; N A Jenkins; A G Farr; S F Ziegler; P J Morrissey; R Paxton; J E Sims
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

8.  FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration.

Authors:  Alessandra Castiglioni; Gianfranca Corna; Elena Rigamonti; Veronica Basso; Michela Vezzoli; Antonella Monno; Albert E Almada; Anna Mondino; Amy J Wagers; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.